PROVIDER PROFILE · NPI 1851512842

Julie RoweM.D.

Hematology-OncologyHouston, TXI

MEDICARE UTILIZATION · PART B · 2024

Total beneficiaries

139

Unique beneficiaries

—

Total services

234

Distinct HCPCS

Medicare payment

$18K

Peer benchmark

Total Medicare services vs. 613 Hematology-Oncology providers in TX — bottom quintile (cohort median 2,625).

PRESCRIBING · PART D · 2024

Total Rx claims

605

Beneficiaries

—

Total drug cost

$2.5M

Distinct drugs

Brand share

44.3%

Top prescribed drugs

Lenvatinib Mesylate61 claims

Hydrocodone/Acetaminophen54 claims

Levothyroxine Sodium44 claims

Prochlorperazine Maleate40 claims

Ondansetron Hcl37 claims

QUALITY · MIPS · 2024

Final MIPS score

84.1

Quality

69.2

Cost

73.6

Improvement activities

40.0

Promoting interop.

100.0

Payment adjustment

0.38%

Group

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

Total received

$141

Payment records

By payment type

Food and Beverage$141

Top paying entities

Food and Beverage$141

REFERRAL NETWORK

Where Julie Rowe's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 3 inbound referrers · 0 outbound destinations.

Receives referrals from

Inbound — who sends patients here

Physician	Patients	Visits
MEMORIAL HERMANN HEALTH SYSTEM	14	59
Daniel Ocazionez Trujillo Diagnostic Radiology · Houston, TX	12	42
OLDHAM, SANDRA	11	50

Refers patients to

Outbound — where patients go next

No outbound pairs above the suppression threshold.

Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore

OIG/SAM exclusion screening, sanctions history